Earnings Labs
PL

Polaryx Therapeutics, Inc. Common Stock (PLYX)

NASDAQ·Healthcare·Biotechnology

$5.62

+10.75%

Mkt Cap $240.03M

No analyst coverage available

We don't have analyst ratings or price target data for Polaryx Therapeutics, Inc. Common Stock yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.